Stock Track | ANI Pharmaceuticals Plummets 5.17% Intraday Despite Strong Earnings as Health Care Sector Weakens

Stock Track

Feb 28

ANI Pharmaceuticals Inc. (ANIP) shares plummeted 5.17% during intraday trading on Friday, marking a significant downturn despite the company reporting record quarterly financial results.

The pharmaceutical firm posted fourth-quarter adjusted earnings of $2.33 per share, surpassing the analyst consensus estimate of $2.00. Revenue for the quarter reached $247.1 million, a 29.6% year-over-year increase that also exceeded expectations, driven by a 50.8% surge in Rare Disease segment sales.

The sharp decline occurred amid broader weakness in the health care sector, with the State Street Health Care Select Sector SPDR ETF (XLV) falling 0.3% in pre-market trading. Market participants appeared to engage in profit-taking following the earnings beat, a common "sell the news" reaction, particularly as technical indicators had previously signaled bearish pressure with the MACD below its signal line.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1111911116"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1111911116\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1111911116?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-28 00:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111911116","market":"nz","top_or_hot":-1,"title":"Stock Track | ANI Pharmaceuticals Plummets 5.17% Intraday Despite Strong Earnings as Health Care Sector Weakens","media":"Stock Track","content":"<p>ANI Pharmaceuticals Inc. (ANIP) shares plummeted 5.17% during intraday trading on Friday, marking a significant downturn despite the company reporting record quarterly financial results.</p><p>The pharmaceutical firm posted fourth-quarter adjusted earnings of $2.33 per share, surpassing the analyst consensus estimate of $2.00. Revenue for the quarter reached $247.1 million, a 29.6% year-over-year increase that also exceeded expectations, driven by a 50.8% surge in Rare Disease segment sales.</p><p>The sharp decline occurred amid broader weakness in the health care sector, with the State Street Health Care Select Sector SPDR ETF (XLV) falling 0.3% in pre-market trading. Market participants appeared to engage in profit-taking following the earnings beat, a common \"sell the news\" reaction, particularly as technical indicators had previously signaled bearish pressure with the MACD below its signal line.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | ANI Pharmaceuticals Plummets 5.17% Intraday Despite Strong Earnings as Health Care Sector Weakens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | ANI Pharmaceuticals Plummets 5.17% Intraday Despite Strong Earnings as Health Care Sector Weakens\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-28 00:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ANI Pharmaceuticals Inc. (ANIP) shares plummeted 5.17% during intraday trading on Friday, marking a significant downturn despite the company reporting record quarterly financial results.</p><p>The pharmaceutical firm posted fourth-quarter adjusted earnings of $2.33 per share, surpassing the analyst consensus estimate of $2.00. Revenue for the quarter reached $247.1 million, a 29.6% year-over-year increase that also exceeded expectations, driven by a 50.8% surge in Rare Disease segment sales.</p><p>The sharp decline occurred amid broader weakness in the health care sector, with the State Street Health Care Select Sector SPDR ETF (XLV) falling 0.3% in pre-market trading. Market participants appeared to engage in profit-taking following the earnings beat, a common \"sell the news\" reaction, particularly as technical indicators had previously signaled bearish pressure with the MACD below its signal line.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ANIP","symbol_name":"ANI Pharmaceuticals, Inc.","start_time":0,"source_url":"","article_id":"1111911116","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111911116","pubTimestamp":1772209464,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"ANI Pharmaceuticals Inc. (ANIP) shares plummeted 5.17% during intraday trading on Friday, marking a significant downturn despite the company reporting record quarterly financial results.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ANIP":"ANI Pharmaceuticals, Inc."},"translate_title":"个股追踪|ANI制药盘中暴跌5.17%尽管医疗保健板块走弱盈利强劲","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANIP":1},"content_text":"ANI Pharmaceuticals Inc. (ANIP) shares plummeted 5.17% during intraday trading on Friday, marking a significant downturn despite the company reporting record quarterly financial results.The pharmaceutical firm posted fourth-quarter adjusted earnings of $2.33 per share, surpassing the analyst consensus estimate of $2.00. Revenue for the quarter reached $247.1 million, a 29.6% year-over-year increase that also exceeded expectations, driven by a 50.8% surge in Rare Disease segment sales.The sharp decline occurred amid broader weakness in the health care sector, with the State Street Health Care Select Sector SPDR ETF (XLV) falling 0.3% in pre-market trading. Market participants appeared to engage in profit-taking following the earnings beat, a common \"sell the news\" reaction, particularly as technical indicators had previously signaled bearish pressure with the MACD below its signal line.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}